356522-47-9 Usage
Chemical structure
The compound consists of a piperidine ring with a carboxylic acid group at the 2-position and a sulfonyl group attached to the piperidine nitrogen, with a nitrophenyl group attached to the sulfonyl group.
Pharmaceutical industry use
It is often used as an intermediate in the synthesis of various drugs, particularly in the development of potential anti-inflammatory, analgesic, and anti-cancer agents.
Research laboratory use
Utilized as a building block for the synthesis of new chemical entities for biological studies.
Importance in pharmacology
The presence of the sulfonyl and nitrophenyl groups on the piperidine ring makes this compound important for its potential pharmacological activity.
Role in drug discovery and development
It serves as a key building block in drug discovery and development due to its unique chemical structure and potential pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 356522-47-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,6,5,2 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 356522-47:
(8*3)+(7*5)+(6*6)+(5*5)+(4*2)+(3*2)+(2*4)+(1*7)=149
149 % 10 = 9
So 356522-47-9 is a valid CAS Registry Number.
356522-47-9Relevant articles and documents
Pipecolate-sulfonamides for treatment of psychiatric disorders
-
, (2013/07/25)
The present invention relates to compounds having a pipecolate sulfonamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable
PIPECOLATE-SULFONAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS
-
, (2013/07/19)
The present invention relates to compounds having a pipecolate sulfonamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable
Pipecolic acid derivatives as small-molecule inhibitors of the legionella MIP protein
Juli, Christina,Sippel, Martin,J?ger, Jens,Thiele, Alexandra,Weiwad, Matthias,Schweimer, Kristian,R?sch, Paul,Steinert, Michael,Sotriffer, Christoph A.,Holzgrabe, Ulrike
, p. 277 - 283 (2011/03/22)
The macrophage infectivity potentiator (MIP) protein is a major virulence factor of Legionella pneumophila, the causative agent of Legionnaires disease. MIP belongs to the FK506-binding proteins (FKBP) and is necessary for optimal intracellular survival a
